According to Our latest research report on “Nuclear Medicine Market” highlights the substantial global expansion occurring within this sector. The report encompasses projections for the years leading up to 2031, accompanied by a comprehensive analysis of the market’s current size, prevailing trends, market share, and economic insights.
The world radiopharmaceuticals market is expected to generate a revenue of $8,207.5 million by 2022, the market is currently in its growth stage driven by increasing number of cancer cases and rising awareness about nuclear medicine. Radiopharmaceuticals are pharmaceutical formulations comprising radioactive isotopes that are used in diagnosis and therapeutics. They are simple and small substances that contain a radioactive substance that is used in the treatment of cancer and cardiac & neurological disorders. The conventional chemotherapy methods are being replaced by more convenient therapeutic radiopharmaceuticals for oncology and cancer treatment, which opens up new avenues in the radiopharmaceuticals market. Moreover, it not only helps physicians during diagnosis, but also works as a convenient and safer alternative for patients as compared to X-Rays and other external radiation imaging devices.
Request To Download Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=26911
Radiopharmaceuticals, also known as nuclear medicines, are used in applications such as lymphoma and bone metastasis. F-18, Tc-99, Ga-67, and I-123 are some of the nuclear medicines used in diagnostic procedures, while I-131, Ir-192, Y-90, I-125, Lu-177, and Ra-223 are used in therapeutics procedures.
Convenience of the treatment with minimally invasive techniques attracts more patients towards radiopharmaceuticals mode of treatment as compared to chemotherapy. The factors that drive the Radiopharmaceuticals Industry include increasing incidence of cardiac patients and adoption of clear imaging technique, with the help of diagnostic equipment such as PET and SPECT. The factors that restrain the growth of the market include supply shortages, logistical difficulties, and limited number of trained medical personnel.
The report segments the radiopharmaceuticals industry on the basis of type, modality, application, end user, and geography. On the basis of type, the market is segmented into diagnostic, therapeutic, and research. Based on modality, the nuclear medicine market is segregated into SPECT, PET, alpha emitters, beta emitters, and brachytherapy. According to application, the market is classified into oncology, cardiology, neurology, thyroid, and others. The geographic breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific is the highest revenue generating region accounting for about 35.1% of the total market and is projected to grow at a high CAGR of 8.4% during the forecast period.
Download Free Sample of This Strategic Report:https://reportocean.com/industry-verticals/sample-request?report_id=26911
KEY BENEFITS FOR STAKEHOLDERS:
This report provides an extensive analysis of the current and emerging market trends and dynamics in the world nuclear medicine market.
This report includes a detailed quantitative analysis of the current market and estimations from 2014 to 2022, which contribute in identifying the key market opportunities for growth.
Exhaustive analysis of the world radiopharmaceuticals market by type helps in understanding the types of radiopharmaceuticals that are currently being used along with the variants that would gain prominence in the future.
Competitive intelligence (of leading manufacturers of radiopharmaceuticals) helps in understanding the competitive scenario across the geographies.
Key market players within the radiopharmaceuticals market are profiled in this report and their strategies are analyzed thoroughly. This helps in understanding the competitive outlook of the global nuclear medicine market.
Comprehensive competitive analysis and profiles of major market players such asMallinckrodt plc., General Electric Co. (healthcare division), Medtronic, Inc., Bayer AG, Cardinal Health, Inc., Lantheus Medical Imaging, Inc., and IBA Group is also provided in this report.
NEUCLEAR MEDICINE/ RADIOPAHRMACEUTICALS MARKET KEY SEGMENTS:
By Type
Diagnostic
Therapeutic
By Modality
SPECT
PET
Alpha-emitters
Beta-emitters
Brachytherapy
By Application
Oncology
Cardiology
Neurology
Thyroid
Others
By Procedures
Oncology
Cardiovascular
Central Nervous System
Endocrine
Skeletal
Gastrointestinal
Genito-urinary
Pulmonary
PET & PET-CT
Therapeutic
Others
By End-user
Hospitals and diagnostic centers
Research institutes
Request To Download Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=26911
By Geography
North America
U.S.
Canada
Mexico
Europe
Belarus
Czech Republic
Greece
Hungary
Rest of Europe
Asia-Pacific
China
India
Korea
Pakistan
Rest of Asia-Pacific
LAMEA
Brazil
Argentina
South Africa
Rest of LAMEA
Table of Contents:
- Introduction and Scope
- Definition and Forecast Parameters
- Methodology and Forecast Parameters
- Information Sources
- Latest Trends Summary
- Regional Trends
- Product Trends
- End-Use Trends
- Business Trends
- Industry Insights
- Industry Fragmentation
- Industry Landscape
- Vendor Matrix
- Technological and Innovative Landscape
- Market by Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
- Company Profiles
- Company Overview
- Financial Elements
- Product Landscape
- SWOT Analysis
- Systematic Outlook
Why is Our research important?
- Your research helps in understanding the current market dynamics, trends, and growth prospects of the patient engagement solutions market.
- This knowledge is crucial for businesses, investors, and stakeholders to make informed decisions and develop effective strategies.
- By analyzing the market landscape, identifying key market players, and evaluating market segments and regions, your research helps in identifying potential business opportunities within the patient engagement solutions market.
- Your research report provides forecasts and projections for the future growth of the patient engagement solutions market.
- This helps businesses in estimating market potential, assessing market risks, and planning for future investments and initiatives.
- Your research includes a competitive landscape analysis, highlighting the key players in the patient engagement solutions market and their strategies.
- This information assists businesses in understanding their competitors, their market position, and their strengths and weaknesses. It also helps in benchmarking and developing competitive strategies.
- Your research provides insights into the latest industry trends, technological advancements, and regulatory developments related to patient engagement solutions.
- This information helps businesses stay updated with the industry landscape and adapt to the changing market conditions.
- By providing comprehensive and reliable data, analysis, and insights, your research serves as a valuable resource for decision-making.
- It helps businesses, investors, and stakeholders in making well-informed decisions regarding market entry, product development, partnerships, investments, and other strategic initiatives.
- This information enables businesses to target specific areas for growth and expansion.
Key Questions the Report Discusses
- What essential elements emerged from both primary and secondary research?
- What will the market’s future potential be?
- Who examines the market report’s complete outcome?
- What obstacles and problems face the growth of an industry?
- What does supply chain analysis for products and market size, share mean?
- Which of the possible manufacturers is still operating in the market?
- What are the advantages, benefits, and applications of the product’s features?
- What are the main trends and influencing factors?
Request full Report: https://reportocean.com/industry-verticals/sample-request?report_id=26911
About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean is the world’s leading research company, known for its informative research reports. We are committed to providing our clients with both quantitative and qualitative research results. As a part of our global network and comprehensive industry coverage, we offer in-depth knowledge, allowing informed and strategic business conclusions to report. We utilize the most recent technology and analysis tools along with our own unique research models and years of expertise, which assist us to create necessary details and facts that exceed expectations.
Get in Touch with Us:
Report Ocean:
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES
Tel: +1888 212 3539 (US – TOLL FREE)
Email: sales@reportocean.com
Visit our news website: https://reportocean.com